Intelligence · Clinical Pipeline
Théa Pharma Ireland Pipeline
All ClinicalTrials.gov programs at Théa Pharma Ireland — phase, modality, and trial IDs.
- Programs
- 11
Quick answer
Théa Pharma Ireland has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
FLUOROURACIL, DOCETAXEL, OPDIVO 10 mg/mL concentrate for solution for infusion., OXALIPLATIN, CALCIUM LEVOFOLINATE, CISPLATIN, DOXORUBICIN HYDROCHLORIDE
Verona Pharma Ireland Limited
Gastric adenocarcinoma with peritoneal metastases
1 trial -
Safinamide 100 mg PLACEBO: Safinamide 100 mg PLACEBO film-coated tablets have the same composition as the relevant Investigational Medicinal Products except for the presence of Active Substance that is missing in the placebo formulations. The missing amount of active substance Safinamide methanesulfonate is replaced in the PLACEBO formulation with the same amount of Microcrystalline cellulose, one of the excipients already present in the authorised formulation, Xadago 100 mg film-coated tablets, Xadago 50 m
Verona Pharma Ireland Limited
PARKINSON’S DISEASE WITH MOTOR FLUCTUATIONS
1 trial -
Lynparza 150 mg film-coated tablets, Lynparza 100 mg film-coated tablets
Verona Pharma Ireland Limited
Patients with metastatic PDAC, who have not progressed following completion of at least 16 weeks (can be more) of any multiagent first-line chemotherapy
1 trial -
TAMOXENE 20 mg compresse rivestite con film
Verona Pharma Ireland Limited
cystic fibrosis
1 trial -
Teicoplanina Sandoz 200 mg polvere e solvente per soluzione iniettabile o infusione o soluzione orale
Verona Pharma Ireland Limited
cystic fibrosis associated to persistent Staphylococcus aureus (including MRSA) infection
1 trial -
XEOMIN, 100 unità, polvere per soluzione iniettabile
Verona Pharma Ireland Limited
multifocal spasticity of the upper and lower limb due to cerebral palsy
1 trial -
A randomised, open-label, parallel group study to compare the pharmacokinetics and pharmacodynamics of NEODIDRO® 0.266 mg vs DIBASE® 25,000 IU oral doses in male and female patients.
Verona Pharma Ireland Limited
Patients with low Vitamin D plasma level
1 trial -
Mayzent 0.25 mg film-coated tablets, Mayzent 2 mg film-coated tablets
Verona Pharma Ireland Limited
patients with secondary progressive MS
1 trial -
Mayzent 0.25 mg film-coated tablets, Mayzent 2 mg film-coated tablets, Mayzent 1 mg film-coated tablets, BAF312, BAF312, BAF312
Verona Pharma Ireland Limited
Active progressive multiple sclerosis course after an initial relapse clinical course
1 trial -
Zaredrop 75 mg/ml soluzione orale, Laroxyl 40 mg/ml gocce orali soluzione, FLUOXETINA DOC Generici 20 mg/5 ml Soluzione orale, Zoloft 20 mg/ml concentrato per soluzione orale, Brintellix 20 mg/ml oral drops, solution, Daparox 33,1 mg/ml, gocce orali, soluzione., CITALOPRAM ABC 40 mg/ml gocce orali, soluzione, ESCITALOPRAM DOC 20 mg/ml gocce orali, soluzione
Verona Pharma Ireland Limited
Patients with currently remitted depressive disorders.
1 trial -
Zeposia 0.92 mg hard capsules
Verona Pharma Ireland Limited
Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive)
1 trial
Frequently asked questions
How many pipeline programs does Théa Pharma Ireland have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs